Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
Merih Altintas,1 Leman Inanc,2 Gamze Akcay Oruc,1 Selim Arpacioglu,1 Huseyin Gulec1 1Department of Psychiatry, Erenköy Mental and Neurological Diseases Training and Research Hospital, Istanbul, 2Department of Psychiatry, Dr Cevdet Aykan Mental Health and Diseases Hospital, Tokat, Turkey Bac...
Guardado en:
Autores principales: | Altintas M, Inanc L, Oruc GA, Arpacioglu S, Gulec H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e99f42aaa004bed821206f16a7544f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
por: L. A. Ivanova, et al.
Publicado: (2017) -
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
por: Leontina Elena Filipiuc, et al.
Publicado: (2021) -
Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
por: Rachit Sharma, et al.
Publicado: (2021) -
Empathy and Its Relationship With Social Functioning in Individuals at Ultra-High Risk for Psychosis
por: Daan Jan Kuis, et al.
Publicado: (2021) -
Neurocognition and Social Cognition— Possibilities for Diagnosis and Treatment in Ultra-High Risk for Psychosis State
por: Katarzyna Rek-Owodziń, et al.
Publicado: (2021)